New Zealand markets closed

U.S. Physical Therapy, Inc. (USPH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
101.56+0.05 (+0.05%)
At close: 04:00PM EDT
101.56 0.00 (0.00%)
After hours: 04:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.53B
Enterprise value 1.64B
Trailing P/E 79.34
Forward P/E 39.53
PEG ratio (5-yr expected) 6.94
Price/sales (ttm)2.38
Price/book (mrq)3.21
Enterprise value/revenue 2.71
Enterprise value/EBITDA 22.00

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3-6.39%
S&P500 52-week change 323.57%
52-week high 3124.11
52-week low 378.08
50-day moving average 3104.75
200-day moving average 397.97

Share statistics

Avg vol (3-month) 371.85k
Avg vol (10-day) 360.87k
Shares outstanding 515.07M
Implied shares outstanding 615.56M
Float 814.81M
% held by insiders 11.66%
% held by institutions 1105.38%
Shares short (15 Apr 2024) 4619.71k
Short ratio (15 Apr 2024) 48.13
Short % of float (15 Apr 2024) 45.52%
Short % of shares outstanding (15 Apr 2024) 44.11%
Shares short (prior month 15 Mar 2024) 4745.89k

Dividends & splits

Forward annual dividend rate 41.76
Forward annual dividend yield 41.73%
Trailing annual dividend rate 31.72
Trailing annual dividend yield 31.69%
5-year average dividend yield 41.27
Payout ratio 4134.38%
Dividend date 305 Apr 2024
Ex-dividend date 411 Mar 2024
Last split factor 23:2
Last split date 329 Jun 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 4.72%
Operating margin (ttm)10.84%

Management effectiveness

Return on assets (ttm)4.69%
Return on equity (ttm)6.55%

Income statement

Revenue (ttm)598.63M
Revenue per share (ttm)42.19
Quarterly revenue growth (yoy)9.60%
Gross profit (ttm)N/A
EBITDA 85.25M
Net income avi to common (ttm)18.14M
Diluted EPS (ttm)1.28
Quarterly earnings growth (yoy)-74.80%

Balance sheet

Total cash (mrq)155.49M
Total cash per share (mrq)10.32
Total debt (mrq)258.59M
Total debt/equity (mrq)39.65%
Current ratio (mrq)2.28
Book value per share (mrq)31.77

Cash flow statement

Operating cash flow (ttm)81.98M
Levered free cash flow (ttm)65.97M